Rationale and Design of the Impact of Air Pollution Due to DESERT Dust in Patients with HEART Failure (DESERT HEART).
air pollution
airway inflammation
chronic heart failure
desert dust
design study
haze
oxidative stress
pulmonary inflammation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Jul 2023
29 Jul 2023
Historique:
received:
16
06
2023
revised:
25
07
2023
accepted:
27
07
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
The main objective of this study is to determine whether exposure to Saharan dust causes airway inflammation and oxidative stress in patients with stable chronic heart failure (HF) and a left ventricular ejection fraction of less than 40%. A longitudinal study design is used, involving the inclusion of 40 patients with stable chronic HF and a left ventricular ejection fraction of less than 40%. Four sputum samplings will be taken from each patient, with one sampling taken each week over four consecutive weeks. The sputum samples will be used to analyze the degree of inflammation and oxidative stress. Air quality monitoring stations will be used to analyze the particulate matter (PM) exposure of each patient. The intrusion of desert dust will be identified using meteorological models. There will be 160 scheduled samplings in 40 patients with chronic HF. Mixed regression models will be used to assess the influence of the concentrations of PM (from the episodes of desert dust) upon the airway inflammation and oxidative stress markers. The results of this study will test the hypothesis that exposure to high concentrations of Saharan dust affects the normal function of the respiratory epithelium due to the imbalance between the production of free radicals and antioxidant enzymes, thus causing increased pulmonary inflammation and oxidative stress in patients with HF that in turn may facilitate decompensations of their background disease condition.
Identifiants
pubmed: 37568392
pii: jcm12154990
doi: 10.3390/jcm12154990
pmc: PMC10420286
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI21/00404
Organisme : Sociedad Española de Cardiología
ID : SEC/FEC-INV-CLI 22/25
Références
Emergencias. 2017 Jun;29(3):185-193
pubmed: 28825240
Occup Environ Med. 2012 Dec;69(12):908-15
pubmed: 23085558
Circulation. 2019 Dec 10;140(24):1995-2004
pubmed: 31744317
Epidemiology. 2008 Nov;19(6):808-9
pubmed: 18854705
Lancet. 2018 Feb 3;391(10119):462-512
pubmed: 29056410
Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):538
pubmed: 35190289
Emergencias. 2021 Dec;33(6):413-420
pubmed: 34813187
Clin Biochem. 1996 Jun;29(3):225-9
pubmed: 8740508
Stat Methods Med Res. 2016 Apr;25(2):686-705
pubmed: 23221975
Environ Int. 2012 Oct 15;47:107-14
pubmed: 22796892
Part Fibre Toxicol. 2009 Sep 18;6:24
pubmed: 19761620
Anal Biochem. 1992 May 1;202(2):249-55
pubmed: 1519749
Eur J Heart Fail. 2022 Jan;24(1):4-131
pubmed: 35083827
J Clin Med. 2021 Feb 12;10(4):
pubmed: 33673156
Int J Epidemiol. 2013 Aug;42(4):1187-95
pubmed: 23760528
Emergencias. 2019 Jun;31(3):161-166
pubmed: 31210447
Environ Health. 2017 Nov 21;16(1):126
pubmed: 29157250
Lancet. 2013 Sep 21;382(9897):1039-48
pubmed: 23849322
Monaldi Arch Chest Dis. 2009 Sep;71(3):119-26
pubmed: 19999958
Stat Med. 2010 Jan 30;29(2):181-92
pubmed: 19899065